I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| microglial cell | 6 studies | 26% ± 12% | |
| ciliated cell | 4 studies | 25% ± 4% | |
| GABAergic neuron | 3 studies | 27% ± 4% | |
| glutamatergic neuron | 3 studies | 34% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| microglial cell | 6 studies | 26% ± 12% | |
| ciliated cell | 4 studies | 25% ± 4% | |
| GABAergic neuron | 3 studies | 27% ± 4% | |
| glutamatergic neuron | 3 studies | 34% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 25% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2171.00 | 1438 / 1445 | 99% | 5.03 | 182 / 183 |
| ovary | 100% | 2543.79 | 180 / 180 | 99% | 4.87 | 424 / 430 |
| thymus | 100% | 3013.96 | 653 / 653 | 98% | 7.13 | 595 / 605 |
| brain | 99% | 1483.84 | 2613 / 2642 | 99% | 5.88 | 701 / 705 |
| prostate | 100% | 2260.88 | 245 / 245 | 97% | 3.15 | 489 / 502 |
| kidney | 100% | 1090.26 | 89 / 89 | 97% | 3.35 | 871 / 901 |
| intestine | 100% | 2046.60 | 964 / 966 | 94% | 2.82 | 498 / 527 |
| uterus | 100% | 3394.16 | 170 / 170 | 94% | 4.13 | 430 / 459 |
| pancreas | 96% | 686.48 | 315 / 328 | 97% | 2.77 | 172 / 178 |
| lung | 99% | 1530.10 | 575 / 578 | 93% | 4.07 | 1071 / 1155 |
| breast | 100% | 1311.24 | 459 / 459 | 92% | 2.74 | 1030 / 1118 |
| stomach | 98% | 1416.86 | 351 / 359 | 93% | 3.38 | 267 / 286 |
| adrenal gland | 99% | 999.20 | 256 / 258 | 84% | 3.74 | 194 / 230 |
| skin | 85% | 704.36 | 1535 / 1809 | 94% | 3.53 | 444 / 472 |
| bladder | 100% | 2023.57 | 21 / 21 | 79% | 2.32 | 396 / 504 |
| blood vessel | 100% | 2639.16 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 6.28 | 80 / 80 |
| spleen | 100% | 1579.60 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 4.54 | 45 / 45 |
| adipose | 100% | 1301.66 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| heart | 98% | 1499.26 | 844 / 861 | 0% | 0 | 0 / 0 |
| muscle | 96% | 681.77 | 768 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 79% | 1.71 | 23 / 29 |
| liver | 42% | 171.20 | 95 / 226 | 34% | 0.81 | 138 / 406 |
| peripheral blood | 8% | 32.61 | 73 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_2000271 | Biological process | positive regulation of fibroblast apoptotic process |
| GO_0010468 | Biological process | regulation of gene expression |
| GO_0043408 | Biological process | regulation of MAPK cascade |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0032259 | Biological process | methylation |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0051726 | Biological process | regulation of cell cycle |
| GO_0030308 | Biological process | negative regulation of cell growth |
| GO_0005829 | Cellular component | cytosol |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| GO_0003682 | Molecular function | chromatin binding |
| GO_0008168 | Molecular function | methyltransferase activity |
| Gene name | PRDM11 |
| Protein name | PR domain-containing protein 11 (EC 2.1.1.-) Alternative protein PRDM11 PR/SET domain 11 |
| Synonyms | PFM8 |
| Description | FUNCTION: May be involved in transcription regulation. . |
| Accessions | ENST00000424263.6 [Q9NQV5-2] ENST00000622142.5 ENST00000683152.1 A0A087WWZ6 L8E8J9 ENST00000530656.5 [Q9NQV5-2] ENST00000534751.3 H3BSZ2 Q9NQV5 |
